Adam Inche | Founder & CEO
Lentitek

A scientist by trade, Adam has a PhD in cancer biology from Oxford University and an executive MBA from Edinburgh. After a decade in R&D at AstraZeneca, Applied Biosystems & Lab901, Adam has spent the last 15 years in marketing & commercial roles developing market and product strategy for the likes of Agilent, Merck-BioReliance & Symbiosis.